Composite Grading Algorithm for the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
      QxMD      Google Scholar   
Citation:
Clin Trials vol 18 (1) 104-14
Year:
2021
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
DataSharing:
No
SDC:
Yes
Book Volume:
10
Parents:
3114   3242  
Children:
None
Program:
CCP
Primary Committee:
Health Outcome
Sec. Committees:
Experimental    
Pharmas:
Bayer  
Grants:
UG1CA189823, U10CA180821, U10CA180882, U01 CA233046, HHSN261200800043C, U10CA180790, U10CA180791, U10CA180838, U10CA180857, U10CA180858, U10CA180867, UG1CA189960  
Corr. Author:
 
Authors:
                                         
Networks:
ADM401, ADM403, ALLIANCE, COLUMBIA, LAPS-MA036, LAPS-MN026, LAPS-NC007, LAPS-NC010, LAPS-NY016   
Study
A091105
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: